GonaCon trial in bull calves

GonaCon trial in bull calves

Print / Save as PDF

The GonaCon™ trial in bull calves investigated the efficacy of the immunocontraceptive vaccine GonaCon to:

  1. induce antibodies against the key reproductive hormone gonadotrophin releasing hormone (GnRH) in bull calves, and
  2. suppress testicular growth longer-term.

For more information about this trial, please read the final report summary and download the final report (B.AWW.0241) from the Meat & Livestock Australia website.

When: 1 August 2014 to 30 October 2015

Contact: Michael J. D’Occhio

Collaborator: University of Sydney

Share this resource via

Email
Facebook
LinkedIn
Key details

Date published:

April 2, 2017

Date reviewed:

June 25, 2026

Type:

FutureBeef eBulletin – Subscribe
FutureBeef logo

Subscribe to the FutureBeef eBulletin

Fields marked * are required.

Please confirm your subscription.

Thank you for signing up to start receiving the FutureBeef eBulletin at the email address you provided, please follow the instructions in the confirmation email to subscribe.

Regions of interest

Choose as many as you like.

We value your privacy and will never sell your details.